Page last updated: 2024-10-20

pyrazinamide and Dizziness

pyrazinamide has been researched along with Dizziness in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Dizziness: An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.

Research Excerpts

ExcerptRelevanceReference
" Group II also registered; the maximum cost and highest incidence of adverse effects."2.70Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore. ( Beena, S; Pai, MR; Rao, KN, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beena, S1
Rao, KN1
Pai, MR1

Trials

2 trials available for pyrazinamide and Dizziness

ArticleYear
Comparative evaluation of efficacy and safety profile of three anti-tuberculous regimens in Mangalore.
    Indian journal of medical sciences, 2002, Volume: 56, Issue:7

    Topics: Adult; Antitubercular Agents; Dizziness; Drug Therapy, Combination; Ethambutol; Female; Follow-Up St

2002
A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
    The American review of respiratory disease, 1986, Volume: 134, Issue:1

    Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as

1986